-
EP3713573
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3713573
| EP3713573 - IRON CHELATORS IN TUMOR THERAPY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 09.05.2024 Database last updated on 04.11.2024 | |
| Former | Request for examination was made Status updated on 28.08.2020 | ||
| Former | The international publication has been made Status updated on 01.06.2019 | ||
| Former | unknown Status updated on 07.12.2018 | Most recent event Tooltip | 04.09.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Deutsches Krebsforschungszentrum Im Neuenheimer Feld 280 69120 Heidelberg / DE | [2020/40] | Inventor(s) | 01 /
HOPPE-SEYLER, Felix Weinheimer Str. 7 69493 Hirschberg / DE | 02 /
BRAUN, Julia A. Amselweg 4 68535 Edingen-Neckarhausen / DE | 03 /
HOPPE-SEYLER, Karin Weinheimer Strasse 7 69493 Hirschberg / DE | [2020/40] | Representative(s) | Altmann Stößel Dick Patentanwälte PartG mbB Theodor-Heuss-Anlage 2 68165 Mannheim / DE | [N/P] |
| Former [2020/40] | Altmann Stößel Dick Patentanwälte PartG mbB Dudenstrasse 46 68167 Mannheim / DE | Application number, filing date | 18807975.0 | 23.11.2018 | [2020/40] | WO2018EP82316 | Priority number, date | EP20170203391 | 23.11.2017 Original published format: EP 17203391 | [2020/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019101897 | Date: | 31.05.2019 | Language: | EN | [2019/22] | Type: | A1 Application with search report | No.: | EP3713573 | Date: | 30.09.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.05.2019 takes the place of the publication of the European patent application. | [2020/40] | Search report(s) | International search report - published on: | EP | 31.05.2019 | Classification | IPC: | A61K31/4412, A61K31/16, A61K31/444, A61P35/00 | [2020/40] | CPC: |
A61K31/4412 (EP,US);
A61K31/4418 (US);
A61K31/16 (EP,US);
A61K31/345 (US);
A61K31/4196 (US);
A61K31/44 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/40] | Title | German: | EISENCHELATOREN IN DER TUMORTHERAPIE | [2020/40] | English: | IRON CHELATORS IN TUMOR THERAPY | [2020/40] | French: | CHÉLATEURS DU FER EN THÉRAPIE ANTITUMORALE | [2020/40] | Entry into regional phase | 27.04.2020 | National basic fee paid | 27.04.2020 | Designation fee(s) paid | 27.04.2020 | Examination fee paid | Examination procedure | 23.09.2019 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 27.04.2020 | Examination requested [2020/40] | 27.04.2020 | Date on which the examining division has become responsible | 08.01.2021 | Amendment by applicant (claims and/or description) | 08.05.2024 | Despatch of a communication from the examining division (Time limit: M06) | Fees paid | Renewal fee | 19.11.2020 | Renewal fee patent year 03 | 19.11.2021 | Renewal fee patent year 04 | 18.11.2022 | Renewal fee patent year 05 | 23.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] - WEEMS JESSICA M ET AL, "Abstract 914: Ciclopirox olamine (CPX) inhibits breast cancer cell proliferation by blocking the formation of a PEAK1-Src-eIF5a protein complex", CANCER RESEARCH, & 103RD ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; CHICAGO, IL, USA; MARCH 31 -APRIL 04, 2012, (201204), vol. 72, no. Suppl. 8, doi:10.1158/1538-7445.AM2012-914, XP002779248 [X] 1-8 * abstract * DOI: http://dx.doi.org/10.1158/1538-7445.AM2012-914 | [X] - SHEN TAO ET AL, "Abstract 3408: The anticancer mechanisms of ciclopirox olamine.", CANCER RESEARCH, & 104TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH (AACR); WASHINGTON, DC, USA; APRIL 06 -10, 2013, (201304), vol. 73, no. 8, Suppl. 1, doi:10.1158/1538-7445.AM2013-3408, XP002779249 [X] 1-8 * abstract * DOI: http://dx.doi.org/10.1158/1538-7445.AM2013-3408 | [X] - ZHOU HONGYU ET AL, "The antitumor activity of the fungicide ciclopirox", INTERNATIONAL JOURNAL OF CA, JOHN WILEY & SONS, INC, US, (20100101), vol. 127, no. 10, ISSN 0020-7136, pages 2467 - 2477, XP008132831 [X] 1-8 * page 2467, abstract * | [X] - YANINA EBERHARD ET AL, "Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 114, no. 14, doi:10.1182/BLOOD-2009-03-209965, ISSN 0006-4971, (20091001), pages 3064 - 3073, (20090709), XP009152199 [X] 1-8 * page 3064, abstract * DOI: http://dx.doi.org/10.1182/blood-2009-03-209965 | [X] - FRYKNAS MARTEN ET AL, "Iron chelators target both proliferating and quiescent cancer cells", SCIENTIFIC REPORTS, (20161207), vol. 6, doi:10.1038/srep38343, XP002779250 [X] 1-8 * page 1, abstract * DOI: http://dx.doi.org/10.1038/srep38343 | by applicant | - TORTI; TORTI, Nat Rev Cancer, (20130000), vol. 13, no. 5, pages 342 - 55 | - WARIS; AHSAN, Journal of Carcinogenesis, (20060000), vol. 5, pages 14 - 14 | - SANVISENS et al., Biomed J, (20130000), vol. 36, no. 2, pages 51 - 8 | - CLEMENT et al., Int J. Cancer, (20020000), vol. 100, pages 491 - 498 | - SONG et al., Cancer Res., (20110000), vol. 71, pages 7628 - 7639 | - DE MARTEL et al., IntJ Cancer, (20170000), vol. 141, no. 4, pages 664 - 670 | - DYSON et al., Science, (19890000), vol. 243, no. 4893, pages 934 - 7 | - MARTINEZ-ZAPIEN et al., Nature, (20160000), vol. 529, no. 7587, pages 541 - 5 | - HALL; ALEXANDER, J Viral, (20030000), vol. 77, no. 10, pages 6066 - 9 | - VAUPEL et al., Antioxid Redox Signal, (20070000), vol. 9, no. 8, pages 1221 - 35 | - VAUPEL; MAYER, Cancer Metastasis Rev, (20070000), vol. 26, no. 2, pages 225 - 39 | - HOPPE-SEYLER et al., Proceedings of the National Academy of Sciences, (20170000), vol. 114, no. 6, pages E990 - E998 | - OVERGAARD, J Clin Oncol, (20070000), vol. 25, no. 26, pages 4066 - 74 | - HILI et al., Sem in Radial Oncol, (20150000), vol. 25, no. 4, pages 260 - 72 | - MANOOCHEHRI KHOSHINANI et al., Cancer Invest, (20160000), vol. 34, no. 10, pages 536 - 545 | - SHEN; HUANG, Curr Pharm Des, (20160000), vol. 22, no. 28, pages 4443 - 50 | - ZHOU et al., Journal international du cancer, (20100000), vol. 127, no. 10, pages 2467 - 2477 | - EBERHARD et al., Blood, (20090000), vol. 114, no. 14, pages 3064 - 3073 | - CHEMICAL ABSTRACTS, Database accession no. 29342-05-0 | - CHEMICAL ABSTRACTS, Database accession no. 70-51-9 | - CHEMICAL ABSTRACTS, Database accession no. 127-07-1 | - CHEMICAL ABSTRACTS, Database accession no. 59-87-0 | - CHEMICAL ABSTRACTS, Database accession no. 236392-56-6 | - CHEMICAL ABSTRACTS, Database accession no. 19494-89-4 | - CHEMICAL ABSTRACTS, Database accession no. 201530-41-8 | - CHEMICAL ABSTRACTS, Database accession no. 30652-11-0 | - DE VILLIERS, E. M.; C. FAUQUET; T. R. BROKER; H. U. BERNARD; H. ZUR HAUSEN, "Classification of papillomaviruses", Virology, (20040000), vol. 324, doi:doi:10.1016/j.virol.2004.03.033, pages 17 - 27, XP004512668 DOI: http://dx.doi.org/10.1016/j.virol.2004.03.033 | - Remington's Pharmaceutical Sciences, Mack Publishing Company | - LABERGE et al., Nat. Cell Biol., vol. 17, pages 1049 - 1061 | - HILI et al., Sem In Radial Oncol, (20150000), vol. 25, no. 4, pages 260 - 72 |